Kenji Miki

Title: Kenji Miki: Innovator in Cardiac Myocyte Research

Introduction

Kenji Miki is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of cardiac myocyte research, holding a total of seven patents. His work focuses on innovative methods for enhancing cardiac cell populations derived from stem cells.

Latest Patents

Among his latest patents is a method for enriching cardiac myocytes. This technology aims to improve the collection of atrial and ventricular myocytes from a cardiomyocyte-containing cell population induced from stem cells. The method utilizes the expression level of CD151 as an index for effective enrichment. Another notable patent is the cardiomyocyte maturation promoter, which comprises one or more compounds, including 2-methoxy-5-((Z)-2-(3,4,5-trimethoxyphenyl)vinyl)phenol. This invention is designed to promote the maturation of cardiomyocytes.

Career Highlights

Kenji Miki has worked with esteemed institutions such as Kyoto University and Orizuru Therapeutics, Inc. His research has been pivotal in advancing the understanding of cardiac myocyte development and maturation.

Collaborations

Throughout his career, Miki has collaborated with notable colleagues, including Yoshinori Yoshida and Hirohide Saito. These partnerships have contributed to the success of his research endeavors.

Conclusion

Kenji Miki's innovative work in cardiac myocyte research has led to significant advancements in the field. His patents reflect a commitment to improving cardiac health through scientific innovation.